These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21351243)

  • 1. Metabolic syndrome and nonalcoholic steatohepatitis recurrence after liver transplantation in children.
    Nobili V; Alisi A; de Ville de Goyet J
    Liver Transpl; 2011 May; 17(5):620-1. PubMed ID: 21351243
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Malik SM; Ahmad J
    Liver Transpl; 2010 Apr; 16(4):533. PubMed ID: 20373463
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic syndrome and liver transplantation.
    Kadayifci A
    Panminerva Med; 2009 Dec; 51(4):205-13. PubMed ID: 20195231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
    Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
    Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAFLD recurrence in liver transplant recipients.
    Dureja P; Mellinger J; Agni R; Chang F; Avey G; Lucey M; Said A
    Transplantation; 2011 Mar; 91(6):684-9. PubMed ID: 21248661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome after pediatric liver transplantation.
    Kosola S; Lampela H; Makisalo H; Lohi J; Arola J; Jalanko H; Pakarinen M
    Liver Transpl; 2014 Oct; 20(10):1185-92. PubMed ID: 24923737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo fatty liver due to vascular complications after liver transplantation.
    Zahmatkeshan M; Geramizadeh B; Eshraghian A; Nikeghbalian S; Bahador A; Salahi H; Malek-Hosseini SA
    Transplant Proc; 2011 Mar; 43(2):615-7. PubMed ID: 21440778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
    Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
    Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience.
    Heuer M; Kaiser GM; Kahraman A; Banysch M; Saner FH; Mathé Z; Gerken G; Paul A; Canbay A; Treckmann JW
    Digestion; 2012; 86(2):107-13. PubMed ID: 22846254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic steatohepatitis and the metabolic syndrome.
    Jiang J; Torok N
    Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Verrijken A; Francque S; Mertens I; Prawitt J; Caron S; Hubens G; Van Marck E; Staels B; Michielsen P; Van Gaal L
    Hepatology; 2014 Jan; 59(1):121-9. PubMed ID: 24375485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome.
    El Atrache MM; Abouljoud MS; Divine G; Yoshida A; Kim DY; Kazimi MM; Moonka D; Huang MA; Brown K
    Clin Transplant; 2012; 26(5):E505-12. PubMed ID: 23061759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis.
    Manco M; Bedogni G; Marcellini M; Devito R; Ciampalini P; Sartorelli MR; Comparcola D; Piemonte F; Nobili V
    Gut; 2008 Sep; 57(9):1283-7. PubMed ID: 18218674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty liver and the metabolic syndrome.
    Neuschwander-Tetri BA
    Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of nonalcoholic fatty liver disease after liver transplantation: it is common, but does it affect outcome?
    Newsome PN
    Liver Transpl; 2010 Apr; 16(4):420-2. PubMed ID: 20373452
    [No Abstract]   [Full Text] [Related]  

  • 20. [The prevalence of metabolic syndrome in patients with nonalcoholic fatty liver disease].
    Moon KW; Leem JM; Bae SS; Lee KM; Kim SH; Chae HB; Park SM; Youn SJ
    Korean J Hepatol; 2004 Sep; 10(3):197-206. PubMed ID: 15385714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.